2026-04-30
How to Track Biotech Catalysts Without Signal Overload
A signal-first method to track biotech catalysts across FDA, SEC, and clinical milestones without dashboard fatigue.
Catalyst tracking fails when every event looks equally urgent. Biotech teams need ranking logic, not just event feeds.
Group events into regulatory, clinical, and financing streams, then assign impact tiers based on timing, probability, and decision dependency.
A weekly review cadence with a monthly scenario layer is usually enough for small teams to stay current without operational drag.
Meddash consolidates FDA, SEC, and trial milestones into one workflow so teams can prioritize action windows instead of chasing noise.
Next step
Request a Meddash brief to receive decision-ready KOL and catalyst intelligence for your therapeutic area.
Request Brief